1. Lipophilization of Hydroxytyrosol-Enriched Fractions from Olea europaea L. Byproducts and Evaluation of the in Vitro Effects on a Model of Colorectal Cancer Cells
- Author
-
Annalisa Tanini, Isabella Carastro, Roberto Zonefrati, Patrizia Pinelli, Annalisa Romani, Roberta Bernini, Maria Luisa Brandi, and Gaia Palmini
- Subjects
Green chemistry ,Estrogen receptor ,Fraction (chemistry) ,01 natural sciences ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Line, Tumor ,Olea ,Botany ,Estrogen Receptor beta ,Humans ,Doubling time ,Waste Products ,Chromatography ,Molecular Structure ,biology ,Plant Extracts ,010405 organic chemistry ,General Chemistry ,Phenylethyl Alcohol ,biology.organism_classification ,In vitro ,0104 chemical sciences ,chemistry ,Olea europaea L. byproducts, hydroxytyrosol (HTyr), lipophilization of extracts, hydroxytyrosyl esters, colorectal cancer (CRC) ,Cell culture ,030220 oncology & carcinogenesis ,Hydroxytyrosol ,Colorectal Neoplasms ,General Agricultural and Biological Sciences - Abstract
A hydroxytyrosol (HTyr)-enriched fraction containing HTyr 6% w/w, derived from Olea europaea L. byproducts and obtained using an environmentally and economically sustainable technology, was lipophilized under green chemistry conditions. The effects of three fractions containing hydroxytyrosyl butanoate, octanoate, and oleate, named, respectively, lipophilic fractions 5, 6, and 7, and unreacted HTyr on the human colon cancer cell line HCT8-β8 engineered to overexpress estrogen receptor β (ERβ) were evaluated and compared to those of pure HTyr. The experimental data demonstrated that HTyr and all fractions showed an antiproliferative effect, as had been observed by the evaluation of the cellular doubling time under these different conditions (mean control, 32 ± 4 h; HTyr 1, 65 ± 9 h; fraction 5, 64 ± 11 h; fraction 6, 62 ± 14 h; fraction 7, 133 ± 30 h). As evidenced, fraction 7 containing hydroxytyrosyl oleate showed the highest activity. These results were related to the link with ER-β, which was assessed through simultaneous treatment with an inhibitor of ERβ.
- Published
- 2017
- Full Text
- View/download PDF